Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...

The company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...

aNSC: Adult neural stem cell; BM: Bone marrow ... in the striatum can improve motor symptoms in animal models and Parkinson's disease (PD) patients. Open-label clinical studies using fetal ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

It is the first trial in the US to study pluripotent stem cell-derived ... heart disease, and autoimmune disorders. Bayer is also developing a gene therapy for Parkinson's originated by Asklepios ...

Bayer subsidiary BlueRock Therapeutics has dosed the first Parkinson's ... disease progresses. In the BlueRock trial, an unnamed patient has now been administered the first dose of pluripotent ...

2024 — Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a life-threatening side effect called graft-versus-host disease. Results from a clinical ...

Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

Fingernail-sized vibrating gadgets, similar to the tiny devices that make your cellphone buzz, could help people with ...